London Life Sciences Week: What Should Medtech Companies Expect in 2026?

Now that London Life Sciences Week has concluded, a team of our life sciences partners will explore the headwinds and opportunities for medtech companies in 2026.

TOPICS WILL INCLUDE:

• Recapping and summarizing insights learned from London Life Sciences Week
• Understanding the UK/EU and US regulatory landscape for medtech companies, including key issues for transactions
• Exploring how the United States’ approach to tariffs and sanctions are impacting medtech companies and global dealmaking